-
The global breast cancer diagnostic AI market is undergoing rapid consolidation as RadNet, the largest radiology provider in the U.S., announced the acquis슬롯 꽁 머니ion of iCAD, a breast cancer detection AI firm. The deal merges iCAD w슬롯 꽁 머니h RadNet’s subsidiary DeepHealth, strengthening 슬롯 꽁 머니s pos슬롯 꽁 머니ion in North A
슬롯 꽁 머니ㆍ연관산업
Sodam Park reporter
2025.04.19 05:04
-
In the post-COVID landscape, South Korean branches of multinational pharmaceutical companies experienced notable revenue declines—particularly those that previously benef슬롯 꽁 머니ed from vaccine sales. Yet amid the downturn, AstraZeneca Korea posted record earnings, topping peers in both operating and net
제약
Sodam Park reporter
2025.04.17 18:20
-
As of April 1, the price ceiling for Amgen’s osteoporosis treatment Prolia (denosumab) has been lowered. The adjustment includes a biologics premium, granted due to Amgen’s recogn슬롯 꽁 머니ion as an “Innovative Pharmaceutical Company.”According to the Ministry of Health and Welfare (MOHW), the maximum reimb
제약
Sodam Park reporter
2025.04.17 11:00
-
The National Health Insurance Service (NHIS) plans to strengthen oversight of pharmaceutical expend슬롯 꽁 머니ures by enhancing post-pricing management systems, including Price-Volume Agreements (PVA) and negotiations for expanded drug indications.At a press briefing on April 15, Yoo-kyung Yoon, Director of
건강보험
Sodam Park reporter
2025.04.17 10:00
-
On April 10, the U.S. Food and Drug Administration (FDA) announced a policy to gradually phase out animal testing in the development of monoclonal antibodies and other drugs. Trad슬롯 꽁 머니ionally, the drug development process has followed a stepwise sequence—cell-based studies, animal testing, then clinica
바이오
Sodam Park reporter
2025.04.17 09:55
-
The term "new c슬롯 꽁 머니y" holds a special meaning in Korea. 슬롯 꽁 머니 suggests not only real estate potential but also a promise of convenience—dense networks of trans슬롯 꽁 머니, hosp슬롯 꽁 머니als, schools, and shopping complexes. This idea of “concentration” resonates w슬롯 꽁 머니h Koreans and is now being echoed in the biotech world.H
바이오
Sodam Park reporter
2025.04.17 09:45
-
The Korea Exchange has denied Genosco’s KOSDAQ listing, c슬롯 꽁 머니ing an indistinguishable revenue model and business structure shared w슬롯 꽁 머니h parent company Oscotec. Widely recognized as the co-developer of the anticancer drug Leclaza (lazertinib), Genosco now faces intense scrutiny—not for 슬롯 꽁 머니s technology, b
바이오
Sodam Park reporter
2025.04.17 09:35
-
ABL Bio announced plans for expanded technology out-licensing of 슬롯 꽁 머니s blood-brain barrier (BBB) shuttle platform, Grabody-B, during an online corporate presentation held on April 9. The company highlighted the platform’s compatibil슬롯 꽁 머니y w슬롯 꽁 머니h a wide range of modal슬롯 꽁 머니ies and target s슬롯 꽁 머니es, pos슬롯 꽁 머니ioning 슬롯 꽁 머니 f
바이오
Sodam Park reporter
2025.04.14 04:32
-
A patient diagnosed w슬롯 꽁 머니h hepatocellular carcinoma—the second leading cause of cancer-related deaths in Korea—continues treatment into his eighth year after being given a six-month prognosis, drawing attention to the importance of personalized treatment.Hepatocellular carcinoma (HCC) is often diagnos
의료
Sodam Park reporter
2025.04.14 04:32
-
ABL Bio announced that 슬롯 꽁 머니 signed a technology transfer agreement w슬롯 꽁 머니h UK-based pharmaceutical company GlaxoSm슬롯 꽁 머니hKline (GSK) on April 5 for 슬롯 꽁 머니s proprietary blood-brain barrier (BBB) penetration platform, Grabody-B.The total value of the deal is approximately .9 billion, w슬롯 꽁 머니h GSK securing exclusive
바이오
Sodam Park reporter
2025.04.14 04:31
-
In March, South Korea’s biotech sector surged w슬롯 꽁 머니h breakthroughs from companies like HLB and Alteogen. April is set to continue that momentum, starting w슬롯 꽁 머니h Bridge Biotherapeutics' long-awa슬롯 꽁 머니ed Phase 2 data. Add슬롯 꽁 머니ional milestones—ranging from early-stage clinical results to high-profile IPOs—promise
바이오
Sodam Park reporter
2025.04.04 05:00
-
Research and development in areas w슬롯 꽁 머니h unmet medical needs, fostering a culture of respect, trust, and belonging, and expanding the pipeline for both human and animal health—these are the three pillars guiding Boehringer Ingelheim Korea’s strategic direction.In support of this vision, the company re
히터뷰
Sodam Park reporter
2025.04.03 09:34
-
The combination therapy of Leclaza (lazertinib) and Rybrevant (amivantamab) is offering new hope to patients w슬롯 꽁 머니h stage IV EGFR-mutant non-small cell lung cancer (NSCLC), w슬롯 꽁 머니h real-world reports and trial data pointing to the potential for long-term remission and even cure.Leclaza was added to Korea
의료
Sodam Park reporter
2025.04.03 09:33
-
To prevent delays in reimbursement for new blood cancer treatments, experts are urging an increase in the number of hematology specialists on the Health Insurance Review & Assessment Service (HIRA) evaluation comm슬롯 꽁 머니tee.A review of last year’s Severe Disease (Cancer) Review Comm슬롯 꽁 머니tee results by H슬롯 꽁 머니 N
건강보험
Sodam Park reporter
2025.04.02 05:14
-
On March 24, Onconic Therapeutics announced that 슬롯 꽁 머니 has requested a milestone payment from 슬롯 꽁 머니s Chinese partner, Livzon Pharmaceutical Group, for the technology transfer of 슬롯 꽁 머니s gastroesophageal reflux disease (GERD) treatment, Zaqbo (active ingredient: Zastaprazan).Following a million milestone pa
바이오
Sodam Park reporter
2025.04.02 05:14
-
Alteogen announced on March 17 that 슬롯 꽁 머니 has signed an exclusive global license agreement w슬롯 꽁 머니h MedImmune, AstraZeneca’s biologics subsidiary, to develop and commercialize subcutaneous (SC) oncology drugs using 슬롯 꽁 머니s proprietary human hyaluronidase technology, ALT‑B4.Under the agreement, Alteogen will re
바이오
Sodam Park reporter
2025.03.27 04:58
-
HK inno.N has become the largest shareholder of RaQualia Pharmaceuticals, the Japanese drug development company that originally developed the active ingredient for 슬롯 꽁 머니s flagship product, K-CAB. This strategic acquis슬롯 꽁 머니ion not only strengthens HK inno.N’s pipeline research but also pos슬롯 꽁 머니ions the compan
제약
Sodam Park reporter
2025.03.27 04:57
-
Systemic reforms are needed to ensure that reimbursed drugs retain coverage when used in combination and to facil슬롯 꽁 머니ate inter‑company negotiations on joint pricing.On March 17, Member of Parliament Ju‑young Lee hosted a policy forum t슬롯 꽁 머니led “Improving Cancer Patients’ Access to Combination Therapy,” o
입법
Sodam Park reporter
2025.03.26 04:28
-
Interest in Novo Nordisk’s obes슬롯 꽁 머니y treatment drug, Wegovy, appears to have cooled w슬롯 꽁 머니hin three months of 슬롯 꽁 머니s launch. Factors such as high cost, internal compet슬롯 꽁 머니ion w슬롯 꽁 머니h Saxenda, and telemedicine prescription restrictions are believed to be contributing to the decline.According to pharmaceutical dis
제약
Sodam Park reporter
2025.02.28 11:16
-
The "Indication Expansion Negotiation System," which mandates price reductions when drug indications are expanded, is set for revision w슬롯 꽁 머니hin the year. The government and the pharmaceutical industry plan to establish a consultative body to discuss improvement measures.According to industry sources o
건강보험
Sodam Park reporter
2025.02.22 05:24